In conclusion, Orai3 is associated with poor prognosis of lung adenocarcinoma and might be used as a novel prognostic marker for a chemotherapy treatment indication in early stage adenocarcinoma. The gene discussed is ORAI3; the disease is lung adenocarcinoma.